An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients

被引：0
|
作者：
Pollyea, D. A.
Kohrt, H. E.
Rajwanshi, R.
Gallegos, L.
Berube, C.
Coutre, S. E.
Gotlib, J. R.
Liedtke, M.
Mitchell, B. S.
Medeiros, B. C.
机构：
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps280
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS280
引用
收藏
页数：1
相关论文
共 50 条
  • [21] AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN ELDERLY PATIENTS (≥75 YEARS) WITH ACUTE MYELOID LEUKEMIA (AML) IN THE AZA-AML-001 STUDY
    Seymour, J. F.
    Buckstein, R.
    Santini, V.
    Doehner, H.
    Stone, R. M.
    Minden, M. D.
    Kuo, C. Y.
    Ben-Yehuda, D.
    Bargay, J.
    Songer, S.
    Weaver, J.
    Beach, C. L.
    Dombret, H.
    LEUKEMIA RESEARCH, 2017, 55 : S67 - S68
  • [22] A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit
    Manero, Guillermo Garcia
    Atallah, Ehab
    Khaled, Samer K.
    Arellano, Martha
    Patnaik, Mrinal M.
    Odenike, Olatoyosi
    Sayar, Hamid
    Tummala, Mohan
    Patel, Prapti A.
    Ghalie, Richard G.
    Medeiros, Bruno C.
    BLOOD, 2016, 128 (22)
  • [23] A Phase I/II Study of the Combination of Oral Rigosertib and Azacitidine in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
    Navada, Shyamala C.
    Garcia-Manero, Guillermo
    Wilhelm, Francois
    Hearn, Katherine
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Alvarado, Yesid
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Azarnia, Nozar
    Silverman, Lewis R.
    BLOOD, 2014, 124 (21)
  • [24] Phase 2 study of azacitidine (AZA) and venetoclax (VEN) as maintenance therapy for acute myeloid leukemia (AML) patients in remission.
    Bazinet, Alexandre
    Kantarjian, Hagop M.
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Valero, Yesid Alvarado
    Chien, Kelly Sharon
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas James
    Daver, Naval Guastad
    Issa, Ghayas C.
    Jain, Nitin
    Bull-Linderman, Debra
    Dinardo, Courtney Denton
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19018 - E19018
  • [25] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Xia, Leiming
    Tian, Wanlu
    Zhao, Yiming
    Jiang, Lingling
    Qian, Wei
    Jiang, Lei
    Ge, Ling
    Li, Jianjun
    Jin, Fengbo
    Yang, Mingzhen
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [26] COMPARATIVE CLINICAL EFFECTIVENESS OF AZACITIDINE VERSUS DECITABINE FOR THE FRONT LINE TREATMENT OF ELDERLY ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Maurillo, L.
    Candoni, A.
    Spagnoli, A.
    Papayannidis, C.
    Borlenghi, E.
    Lazzarotto, D.
    Fianchi, L.
    Sciume, M.
    Zannier, M. E.
    Buccisano, F.
    Riva, M.
    Breccia, M.
    Fanin, R.
    Todisco, E.
    Lunghi, M.
    De Bellis, E.
    Fracchiolla, N.
    Musto, P.
    Venditti, A.
    Rossi, G.
    HAEMATOLOGICA, 2019, 104 : 89 - 89
  • [27] TREATMENT OF PRACINOSTAT AND AZACITIDINE IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): CORRELATION BETWEEN MUTATION CLEARANCE AND CLINICAL RESPONSE
    Takahashi, K.
    Abaza, Y.
    Wang, F.
    Gumbs, C.
    Xingzhi, S.
    Futreal, A.
    Atallah, E.
    Medeiros, B.
    Khaled, S.
    Arellano, M.
    Patnaik, M.
    Palmesino, E.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2017, 102 : 51 - 52
  • [28] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Leiming Xia
    Wanlu Tian
    Yiming Zhao
    Lingling Jiang
    Wei Qian
    Lei Jiang
    Ling Ge
    Jianjun Li
    Fengbo Jin
    Mingzhen Yang
    Signal Transduction and Targeted Therapy, 8
  • [29] Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
    Winters, Amanda C.
    Gutman, Jonathan A.
    Purev, Enkhtsetseg
    Nakic, Molly
    Tobin, Jennifer
    Chase, Stephanie
    Kaiser, Jeff
    Lyle, Lindsey
    Boggs, Chelsey
    Halsema, Keri
    Schowinsky, Jeffrey T.
    Rosser, Julie
    Ewalt, Mark D.
    Siegele, Bradford
    Rana, Vishal
    Schuster, Steven
    Abbott, Diana
    Stevens, Brett M.
    Jordan, Craig T.
    Smith, Clayton
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2019, 3 (20) : 2911 - 2919
  • [30] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Attar, Eyal C.
    Amrein, Philip C.
    Fraser, James W.
    Fathi, Amir T.
    McAfee, Steven
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Stone, Richard M.
    Foster, Julia
    Neuberg, Donna
    Ballen, Karen K.
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1016 - 1020
12345